Biostem U.S. Corp (US TRADING VENUE: HAIR)
According to the Complaint, the Company describes itself as "developing and commercializing a robotic device, the ARTAS System that assists physicians in performing many of the repetitive tasks that are a part of a follicular unit extraction surgery, a type of hair restoration procedure."
The Complaint alleges that Restoration Robotics negligently issued untrue statements of material facts in, and omitted to state material facts required to be stated from, the Offering Materials issued in connection with the Initial Public Offering. The Complaint further alleges that as a result of the materially misleading Offering Materials, the Company's stock price was artificially inflated at the time of the IPO.